Related Experiment Video

Updated: May 17, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB

H-B Hsiao1, H Lin, J-B Wu

  • 1Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
|November 13, 2012
PubMed
Abstract

Insights

Kinsenoside effectively combats bone loss in ovariectomized mice by inhibiting osteoclast formation and activity. This natural compound prevents osteoporosis by targeting key signaling pathways involved in bone resorption.

Area of Science:

  • Pharmacology and Toxicology
  • Bone Biology and Osteoporosis Research

Background:

  • Kinsenoside, derived from Anoectochilus formosanus, exhibits anti-inflammatory properties.
  • This study explored kinsenoside's potential to inhibit osteoporosis and osteoclastogenesis.

Purpose of the Study:

  • To investigate the anti-osteoporotic effects of kinsenoside in ovariectomized (OVX) mice.
  • To elucidate the underlying mechanisms of kinsenoside's action on osteoclastogenesis and bone resorption.

Main Methods:

  • Ovariectomized mice model to assess anti-osteoporotic activity.
  • Microcomputed tomography for bone microarchitecture analysis.
  • In vitro studies using bone marrow cells and RAW 264.7 cells to determine molecular mechanisms.

Main Results:

  • Kinsenoside significantly suppressed bone loss in OVX mice and reduced plasma CTx levels.
  • In vitro, kinsenoside inhibited osteoclast formation and the expression of key genes like TRAP and MMP-9.
  • Kinsenoside attenuated RANKL-induced NF-κB and NFATc1 signaling pathways, crucial for osteoclast differentiation.

Conclusions:

  • Kinsenoside effectively inhibits osteoclastogenesis by modulating RANKL-induced NF-κB and NFATc1 signaling.
  • These actions prevent bone loss in OVX mice, highlighting kinsenoside's therapeutic potential for osteoporosis.

More Related Videos

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...